Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy

Julia K. Tietze, Danice E C Wilkins, Gail D. Sckisel, Myriam N. Bouchlaka, Kory L. Alderson, Jonathan M. Weiss, Erik Ames, Kevin W. Bruhn, Noah Craft, Robert H. Wiltrout, Dan L. Longo, Lewis L. Lanier, Bruce R. Blazar, Doug Redelman, William J Murphy

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Memory T cells exhibit tremendous antigen specificity within the immune system and accumulate with age. Our studies reveal an antigen-independent expansion of memory, but not naive, CD8+ T cells after several immunotherapeutic regimens for cancer resulting in a distinctive phenotype. Signaling through T-cell receptors (TCRs) or CD3 in both mouse and human memory CD8+ T cells markedly up-regulated programmed death-1 (PD-1) and CD25 (IL-2 receptor α chain), and led to antigen-specific tumor cell killing. In contrast, exposure to cytokine alone in vitro or with immunotherapy in vivo did not up-regulate these markers but resulted in expanded memory CD8 + T cells expressing NKG2D, granzyme B, and possessing broadly lytic capabilities. Blockade of NKG2D in mice also resulted in significantly diminished antitumor effects after immunotherapy. Treatment of TCR-transgenic mice bearing nonantigen expressing tumors with immunotherapy still resulted in significant antitumor effects. Human melanoma tissue biopsies obtained from patients after topically applied immunodulatory treatment resulted in increased numbers of these CD8+ CD25- cells within the tumor site. These findings demonstrate that memory CD8+ T cells can express differential phenotypes indicative of adaptive or innate effectors based on the nature of the stimuli in a process conserved across species.

Original languageEnglish (US)
Pages (from-to)3073-3083
Number of pages11
JournalBlood
Volume119
Issue number13
DOIs
StatePublished - Mar 29 2012

Fingerprint

CD8 Antigens
T-cells
Immunotherapy
Cytokines
T-Lymphocytes
Antigens
Data storage equipment
Tumors
Neoplasms
T-Cell Antigen Receptor
Bearings (structural)
Phenotype
Granzymes
Biopsy
Interleukin-2 Receptors
Immune system
Neoplasm Antigens
Transgenic Mice
Immune System
Melanoma

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Tietze, J. K., Wilkins, D. E. C., Sckisel, G. D., Bouchlaka, M. N., Alderson, K. L., Weiss, J. M., ... Murphy, W. J. (2012). Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy. Blood, 119(13), 3073-3083. https://doi.org/10.1182/blood-2011-07-369736

Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy. / Tietze, Julia K.; Wilkins, Danice E C; Sckisel, Gail D.; Bouchlaka, Myriam N.; Alderson, Kory L.; Weiss, Jonathan M.; Ames, Erik; Bruhn, Kevin W.; Craft, Noah; Wiltrout, Robert H.; Longo, Dan L.; Lanier, Lewis L.; Blazar, Bruce R.; Redelman, Doug; Murphy, William J.

In: Blood, Vol. 119, No. 13, 29.03.2012, p. 3073-3083.

Research output: Contribution to journalArticle

Tietze, JK, Wilkins, DEC, Sckisel, GD, Bouchlaka, MN, Alderson, KL, Weiss, JM, Ames, E, Bruhn, KW, Craft, N, Wiltrout, RH, Longo, DL, Lanier, LL, Blazar, BR, Redelman, D & Murphy, WJ 2012, 'Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy', Blood, vol. 119, no. 13, pp. 3073-3083. https://doi.org/10.1182/blood-2011-07-369736
Tietze, Julia K. ; Wilkins, Danice E C ; Sckisel, Gail D. ; Bouchlaka, Myriam N. ; Alderson, Kory L. ; Weiss, Jonathan M. ; Ames, Erik ; Bruhn, Kevin W. ; Craft, Noah ; Wiltrout, Robert H. ; Longo, Dan L. ; Lanier, Lewis L. ; Blazar, Bruce R. ; Redelman, Doug ; Murphy, William J. / Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy. In: Blood. 2012 ; Vol. 119, No. 13. pp. 3073-3083.
@article{e6e9e8c3b84a493887f2d6b4cc5f7fcf,
title = "Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy",
abstract = "Memory T cells exhibit tremendous antigen specificity within the immune system and accumulate with age. Our studies reveal an antigen-independent expansion of memory, but not naive, CD8+ T cells after several immunotherapeutic regimens for cancer resulting in a distinctive phenotype. Signaling through T-cell receptors (TCRs) or CD3 in both mouse and human memory CD8+ T cells markedly up-regulated programmed death-1 (PD-1) and CD25 (IL-2 receptor α chain), and led to antigen-specific tumor cell killing. In contrast, exposure to cytokine alone in vitro or with immunotherapy in vivo did not up-regulate these markers but resulted in expanded memory CD8 + T cells expressing NKG2D, granzyme B, and possessing broadly lytic capabilities. Blockade of NKG2D in mice also resulted in significantly diminished antitumor effects after immunotherapy. Treatment of TCR-transgenic mice bearing nonantigen expressing tumors with immunotherapy still resulted in significant antitumor effects. Human melanoma tissue biopsies obtained from patients after topically applied immunodulatory treatment resulted in increased numbers of these CD8+ CD25- cells within the tumor site. These findings demonstrate that memory CD8+ T cells can express differential phenotypes indicative of adaptive or innate effectors based on the nature of the stimuli in a process conserved across species.",
author = "Tietze, {Julia K.} and Wilkins, {Danice E C} and Sckisel, {Gail D.} and Bouchlaka, {Myriam N.} and Alderson, {Kory L.} and Weiss, {Jonathan M.} and Erik Ames and Bruhn, {Kevin W.} and Noah Craft and Wiltrout, {Robert H.} and Longo, {Dan L.} and Lanier, {Lewis L.} and Blazar, {Bruce R.} and Doug Redelman and Murphy, {William J}",
year = "2012",
month = "3",
day = "29",
doi = "10.1182/blood-2011-07-369736",
language = "English (US)",
volume = "119",
pages = "3073--3083",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "13",

}

TY - JOUR

T1 - Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy

AU - Tietze, Julia K.

AU - Wilkins, Danice E C

AU - Sckisel, Gail D.

AU - Bouchlaka, Myriam N.

AU - Alderson, Kory L.

AU - Weiss, Jonathan M.

AU - Ames, Erik

AU - Bruhn, Kevin W.

AU - Craft, Noah

AU - Wiltrout, Robert H.

AU - Longo, Dan L.

AU - Lanier, Lewis L.

AU - Blazar, Bruce R.

AU - Redelman, Doug

AU - Murphy, William J

PY - 2012/3/29

Y1 - 2012/3/29

N2 - Memory T cells exhibit tremendous antigen specificity within the immune system and accumulate with age. Our studies reveal an antigen-independent expansion of memory, but not naive, CD8+ T cells after several immunotherapeutic regimens for cancer resulting in a distinctive phenotype. Signaling through T-cell receptors (TCRs) or CD3 in both mouse and human memory CD8+ T cells markedly up-regulated programmed death-1 (PD-1) and CD25 (IL-2 receptor α chain), and led to antigen-specific tumor cell killing. In contrast, exposure to cytokine alone in vitro or with immunotherapy in vivo did not up-regulate these markers but resulted in expanded memory CD8 + T cells expressing NKG2D, granzyme B, and possessing broadly lytic capabilities. Blockade of NKG2D in mice also resulted in significantly diminished antitumor effects after immunotherapy. Treatment of TCR-transgenic mice bearing nonantigen expressing tumors with immunotherapy still resulted in significant antitumor effects. Human melanoma tissue biopsies obtained from patients after topically applied immunodulatory treatment resulted in increased numbers of these CD8+ CD25- cells within the tumor site. These findings demonstrate that memory CD8+ T cells can express differential phenotypes indicative of adaptive or innate effectors based on the nature of the stimuli in a process conserved across species.

AB - Memory T cells exhibit tremendous antigen specificity within the immune system and accumulate with age. Our studies reveal an antigen-independent expansion of memory, but not naive, CD8+ T cells after several immunotherapeutic regimens for cancer resulting in a distinctive phenotype. Signaling through T-cell receptors (TCRs) or CD3 in both mouse and human memory CD8+ T cells markedly up-regulated programmed death-1 (PD-1) and CD25 (IL-2 receptor α chain), and led to antigen-specific tumor cell killing. In contrast, exposure to cytokine alone in vitro or with immunotherapy in vivo did not up-regulate these markers but resulted in expanded memory CD8 + T cells expressing NKG2D, granzyme B, and possessing broadly lytic capabilities. Blockade of NKG2D in mice also resulted in significantly diminished antitumor effects after immunotherapy. Treatment of TCR-transgenic mice bearing nonantigen expressing tumors with immunotherapy still resulted in significant antitumor effects. Human melanoma tissue biopsies obtained from patients after topically applied immunodulatory treatment resulted in increased numbers of these CD8+ CD25- cells within the tumor site. These findings demonstrate that memory CD8+ T cells can express differential phenotypes indicative of adaptive or innate effectors based on the nature of the stimuli in a process conserved across species.

UR - http://www.scopus.com/inward/record.url?scp=84859172050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859172050&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-07-369736

DO - 10.1182/blood-2011-07-369736

M3 - Article

C2 - 22251483

AN - SCOPUS:84859172050

VL - 119

SP - 3073

EP - 3083

JO - Blood

JF - Blood

SN - 0006-4971

IS - 13

ER -